Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Martek Biosciences has entered into a multi-year license and supply agreement with Numico, a specialized nutrition company.
Subscribe to our email newsletter
Under the terms of the agreement, Martek will serve as Numico’s exclusive supplier for all of its ARA (arachidonic acid) and microbially-derived DHA (docosahexaenoic acid) needs for infant formula products. Numico may continue to use alternative non-microbial DHA sources. The agreement provides for a 15-year term, with Numico having the right to terminate the arrangement as of January 2012.
Steve Dubin, Martek’s CEO, said: “With this new agreement, more than 70% of Martek’s business in the infant formula market is subject to multi-year sole source agreements.”